Dissolution techniques for in vitro testing of dry powders for inhalation

Pharmaceutical Research

Volumn 29, Issue 8, 2012, Pages 2157-2166

  May, Sabine ^a   Jensen, Birte ^b   Wolkenhauer, Markus ^b   Schneider, Marc ^a,c   Lehr, Claus Michael ^a,c,d  

^a PharmBioTec GmbH   (Germany)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Aerosol for inhalation; Diffusion; Flow through cell; Franz diffusion cell; Paddle apparatus

Indexed keywords

BUDESONIDE; FENOTEROL;

ARTICLE; DISSOLUTION; DRUG SOLUBILITY; DRY POWDER; FLOW THROUGH CELL; FRANZ DIFFUSION CELL; IN VITRO STUDY; INHALATIONAL DRUG ADMINISTRATION; INTERMETHOD COMPARISON; MATHEMATICAL MODEL; MEMBRANE; PADDLE APPARATUS; PARTICLE SIZE; PRIORITY JOURNAL; REPRODUCIBILITY;

ADMINISTRATION, INHALATION; AEROSOLS; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; DIFFUSION; DRY POWDER INHALERS; EQUIPMENT DESIGN; MEMBRANES, ARTIFICIAL; PARTICLE SIZE; REPRODUCIBILITY OF RESULTS; SOLUBILITY;

EID: 84864489222     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-012-0744-2     Document Type: Article

References (18)

1. Davies NM, Feddah MR. A novel method for assessing dissolution of aerosol inhaler products. Int J Pharm. 2003;255(1-2):175-87.
2. Gray VA, Hickey AJ, Balmer P, Davies NM, Dunbar C, Foster TS, et al. The inhalation ad hoc advisory panel for the USP performance tests of inhalation dosage forms. Pharm Forum. 2008;34(4):1068-74.
3. Jensen B, Reiners M, Wolkenhauer M, Ritzheim P, May S, Schneider M, et al. Dissolution testing for inhaled products. Respiratory Drug Delivery Europe. 2011. Ref Type: Abstract.
4. Henning A, Hein S, Schneider M, Bur M, Lehr CM. Pulmonary drug delivery: medicines for inhalation. 197, 171-192. 2010. Ref Type: Serial (Book, Monograph).
5. Patton JS, Brain JD, Davies LA, Fiegel J, Gumbleton M, Kim KJ, et al. The particle has landed-characterizing the fate of inhaled pharmaceuticals. J Aerosol Med Pulm Drug Deliv. 2010;23 Suppl 2:S71-87.
6. McConville JT, Patel N, Ditchburn N, Tobyn MJ, Staniforth JN, Woodcock P. Use of a novel modified TSI for the evaluation of controlled-release aerosol formulations. I. Drug Dev Ind Pharm. 2000;26(11):1191-8.
7. Cook RO, Pannu RK, Kellaway IW. Novel sustained release microspheres for pulmonary drug delivery. J Control Release. 2005;104(1):79-90.
8. Salama RO, Traini D, Chan HK, Young PM. Preparation and characterisation of controlled release co-spray dried drug-polymer microparticles for inhalation 2: evaluation of in vitro release profiling methodologies for controlled release respiratory aerosols. Eur J Pharm Biopharm. 2008;70(1):145-52.
9. Son YJ, McConville JT. Development of a standardized dissolution test method for inhaled pharmaceutical formulations. Int J Pharm. 2009;382(1-2):15-22.
10. Son YJ, Horng M, Copley M, McConville JT. Optimization of an in vitro dissolution test method for inhalation formulations. Dissolut Technol. 2010;17(2):6-13.
11. Franz TJ. Percutaneous absorption. On the relevance of in vitro data. J Investig Dermatol. 1975;64(3):190-5.
12. Bur M, Huwer H, Muys L, Lehr CM. Drug transport across pulmonary epithelial cell monolayers: effects of particle size, apical liquid volume, and deposition technique. J Aerosol Med Pulm Drug Deliv. 2010;23(3):119-27.
13. Jaspart S, Bertholet P, Piel G, Dogné JM, Delattre L, Evrard B. Solid lipid microparticles as a sustained release system for pulmonary drug delivery. Eur J Pharm Biopharm. 2007;65 (1):47-56.
14. United States Pharmacopeial Convention. Dissolution. United States Pharamacopeia and National Formulary. Maryland: 2011.
15. Petersen H, Kullberg A, Edsbäcker S, Greiff L. Nasal retention of budesonide and fluticasone in man: formation of airway mucosal budesonide-esters in vivo. Br J Clin Pharmacol. 2001;51(2):159-63.
16. Yoshida F, Topliss JG. QSAR model for drug human oral bioavailability. J Med Chem. 2000;43(13):2575-85.
17. European Pharmacopoeia 7.3 online. 2012.
18. Langguth, Fricker, Wunderli-Allenspach. Biopharmazie. Weinheim: Wiley-VCH; 2004.